Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | PYGL | P06737 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | FPR2 | P25090 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4915078 | 1.00 | CA2 (0.50) | CA2CYP2C9PYGLCA1CYP2C19 | |
| SCHEMBL1634494 | 0.89 | MEN1 (0.44) | CA2CYP2C9PYGLCA1CYP2C19 | |
| SCHEMBL1634495 | 0.87 | MEN1 (0.47) | CA2CYP2C9PYGLMEN1KMT2A | |
| SCHEMBL1634493 | 0.86 | POLB (0.52) | CYP2C9MEN1KMT2AALDH1A1 | |
| SCHEMBL1635924 | 0.86 | POLB (0.52) | CYP2C9MEN1KMT2AALDH1A1 | |
| SCHEMBL6224201 | 0.82 | CYP2C9 (0.49) | CA2CYP2C9PYGLCA1CYP2C19 | |
| SCHEMBL7870042 | 0.82 | MEN1 (0.56) | CA2CYP2C9PYGLCA1CYP2C19 | |
| SCHEMBL8657771 | 0.81 | CA2 (0.54) | CA2CYP2C9PYGLCA1CYP2C19 | |
| SCHEMBL21274442 | 0.81 | HPGD (0.60) | CA2CYP2C9PYGLCA1CYP2C19 | |
| SCHEMBL21274439 | 0.81 | HPGD (0.60) | CA2CYP2C9PYGLCA1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080090862-A1 | Isoquinoline Derivatives as Calpain Inhibitors | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2008-04-17 | — | — | US | disclosed |
| EP-1829864-A1 | ISOQUINOLINE DERIVATIVES AS CALPAIN INHIBITORS | Consejo Superior de Investigaciones Cientificas (CSIC) (ES) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006064075-A1 | ISOQUINOLINE DERIVATIVES AS CALPAIN INHIBITORS | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2006-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090862-A1 | Isoquinoline Derivatives as Calpain Inhibitors | CAPN1, CAPN2, CAPNS1 | CA2 398/4885CYP2C9 4359/4885PYGL 3744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.